Alphatec Spine Enters Into Exclusive Distribution Agreement with Parcell Spine
News Jan 14, 2010
Alphatec Holdings, Inc. announced that it has entered into an exclusive distribution agreement with Parcell Spine, LLC, pursuant to which Parcell will license and supply Alphatec Spine with Parcell's proprietary adult stem cells for the treatment of spinal disorders.
The stem cell, which Parcell commercially calls the ELA stem cell, is a unique adult stem cell that possesses self-renewal and bone regenerative capabilities. The cell is isolated from healthy, living adult donors. The ELA stem cell is highly concentrated in that these cells are derived from adult donors using Parcell's proprietary isolation method that has the potential to yield up to six hundred times more cells than a similar volume of mesenchymal stem cells harvested from bone marrow.
The US spinal Biologics market is estimated to be more than $1.5 Billion in 2010.
"The addition of an osteoprogenitor stem cell will provide Alphatec with an excellent position in the growing market of stem cell therapies for treating disorders of the spine, and will be a strong complement to the other innovative technologies in our core fusion and aging spine portfolios," said Dirk Kuyper, the Company's President and CEO.
Mr. Kuyper added, "We are expecting to release this product in the second half of 2010, and we could drive meaningful revenue from this product in 2011. We have been investing heavily into building out our biologics platform to support both our core fusion and aging spine portfolios of products. This product, our Profuse scaffold and the recently announced distribution agreement with ETEX Corporation, are all examples of our focus on providing biologic solutions to improving fusion rates."
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE
Heart-muscle Patches Created from Human Cells Improve Recovery from Heart AttacksNews
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.READ MORE